octopamine has been researched along with urapidil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adler, G; Alt, A; Ditschuneit, HH; Flechtner-Mors, M; Jenkinson, CP | 1 |
| Adler, G; Alt, A; Biesalski, HK; Ditschuneit, HH; Flechtner-Mors, M; Jenkinson, CP | 1 |
1 trial(s) available for octopamine and urapidil
| Article | Year |
|---|---|
In vivo alpha(1)-adrenergic lipolytic activity in subcutaneous adipose tissue of obese subjects.
Topics: Adipose Tissue; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Central Nervous System Depressants; Ethanol; Female; Glycerol; Humans; Lipolysis; Microdialysis; Middle Aged; Norepinephrine; Obesity; Octopamine; Piperazines; Receptors, Adrenergic, alpha-1; Regional Blood Flow; Vasodilator Agents | 2002 |
1 other study(ies) available for octopamine and urapidil
| Article | Year |
|---|---|
Sympathetic regulation of glucose uptake by the alpha1-adrenoceptor in human obesity.
Topics: Adipocytes; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Female; Glucose; Humans; Insulin Resistance; Kinetics; Microdialysis; Middle Aged; Norepinephrine; Octopamine; Piperazines; Receptors, Adrenergic, alpha-1; Sympathetic Nervous System | 2004 |